HealthUS FDA approves Lilly's Mounjaro to reduce cardiovascular risk

Eli Lilly said the U.S. FDA has cleared Mounjaro for reducing the risk of heart attack or stroke among adults with type 2 diabetes who face a high risk of cardiovascular events.

MounjaroEli Lillycardiovascular risk

RReuters★★★☆☆2026-08-28 12:40Original